Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-07-01 | Howard J. Federoff: Ph.D. in Biochemistry and M.D.; CEO and President of Brooklyn ImmunoTherapeutics; experience in life sciences and education. |
Data sourced from SEC filings. Last updated: 2025-07-01